HAVCR1 and hydrops fetalis: Data on the prognostic value of serum KIM-1 in HF are scarce; however, the study designed for investigation of KIM-1 utility in both chronic and acute HF showed that serum KIM-1 is only moderately associated with clinical outcome [90].